Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROMOCRIPTINE vs METHYLERGONOVINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BROMOCRIPTINE vs METHYLERGONOVINE: Safety Overview

Metric BROMOCRIPTINE METHYLERGONOVINE
Total FAERS Reports 864 160
Deaths Reported 75 7
Death Rate 8.7% 4.4%
Hospitalizations 308 84
Average Patient Age 41.4 yrs 31.2 yrs
% Female Patients 57.5% 90.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Zydus Pharmaceuticals USA Inc. Lupin Pharmaceuticals,Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued